ID: ALA4560439

Max Phase: Preclinical

Molecular Formula: C6H5NO2S2

Molecular Weight: 187.25

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  N#CCS(=O)(=O)c1cccs1

Standard InChI:  InChI=1S/C6H5NO2S2/c7-3-5-11(8,9)6-2-1-4-10-6/h1-2,4H,5H2

Standard InChI Key:  JWLFPYPXODBUFB-UHFFFAOYSA-N

Associated Targets(Human)

LXR-beta 3841 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 187.25Molecular Weight (Monoisotopic): 186.9762AlogP: 1.05#Rotatable Bonds: 2
Polar Surface Area: 57.93Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.39CX Basic pKa: CX LogP: 0.75CX LogD: 0.75
Aromatic Rings: 1Heavy Atoms: 11QED Weighted: 0.69Np Likeness Score: -2.42

References

1. Zhang Z, Chen H, Chen Z, Ding P, Ju Y, Gu Q, Xu J, Zhou H..  (2019)  Identify liver X receptor β modulator building blocks by developing a fluorescence polarization-based competition assay.,  178  [PMID:31202993] [10.1016/j.ejmech.2019.06.011]

Source